The poster highlights the importance of medical review and identification of confounding factors when evaluating potential safety signals.
Emeryville, CA (Vocus) October 24, 2010
BioSoteria, Inc., Drug Safety and Risk Management Specialists, announced today that its Senior Vice President, James Buchanan, PharmD, will present the poster titled: "Assessment of Pancreatitis in Chronic Renal Failure during Clinical Development: Role of Medical Assessment in Signal Evaluation." “The poster highlights the importance of medical review and identification of confounding factors when evaluating potential safety signals," says Dr. Buchanan. To download a free copy of the poster, please visit http://www.biosoteria.com/publications.html . His presentation will take place at the fifth Asian Conference on Pharmacoepidemiology in Tokyo, Japan from October 29-31, 2010. The meeting, which is the joint effort of the Asian Conference on Pharmacoepidemiology, the Japanese Society for Pharmacoepidemiology and the International Society of Pharmacoepidemiology, is themed Activities and Co-operation for Drug Safety in Asia. This conference provides an outstanding opportunity for ISPE members to join with eminent Asian regulators, scholars and industry professionals in the field of pharmacoepidemiology.
Founded in 2007 with a strong vision of a progressive drug safety and pharmacovigilance consulting services and education, BioSoteria serves the outsourcing needs of the pharmaceutical industry. From strategic risk management consulting services and full-service drug safety operational capabilities to world-class award winning pharmacovigilance training and education programs, BioSoteria provides unmatched experience, expertise, and leadership to support your company’s efforts to maximize your product’s benefit-risk profile. For more information and to learn more about BioSoteria’s drug safety services and training programs, go to http://www.biosoteria.com.